Edward Morrow Atkinson III, EVP, Chief Technical Operations Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,420 shares at $425.70 ($1.5M) on 2024-02-26, disclosed to the SEC on 2024-02-27.
Scheduled sale ($1.5M) by EVP, Chief Technical Operations Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $431.79 | 1,654 | $714K | 48.7% |
| 2 | $425.70 | 883 | $376K | 25.6% |
| 3 | $425.70 | 883 | $376K | 25.6% |
| Total | $428.65 avg | 3,420 | $1.5M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-12 | $806K | — | Filing → |
| VRTX | SELL | 2025-11-19 | $1.1M | — | Filing → |
| VRTX | SELL | 2025-02-28 | $1.3M | — | Filing → |